Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A indicate a positive outlook. Strong financial metrics, such as a significant increase in in-force business margins and a well-progressed portfolio repositioning, suggest long-term growth. The positive sentiment is reinforced by a robust new business pipeline, strategic capital deployment, and a clear shareholder return plan. While there are some uncertainties in the Q&A, the overall strategic plan and optimistic guidance outweigh these concerns, suggesting a positive stock price movement.
Adjusted EBITDA Increased 18% or $75 million to reach $492 million, reflecting continued commercial momentum, efficiency gains from recent capital investment, and tight cost control over SG&A.
Margin Expanded to 10.1%, up from 8.4% last year, reflecting solid operational performance.
Revenue Came in at $4.9 billion, down 2% from last year, largely due to the effect of lower commodity markets in the U.S.
Net Earnings Were $220 million. On an adjusted basis, net earnings were up 41% at $235 million, and adjusted EPS increased 46% to $0.57, benefiting from stronger earnings and the impact of the share repurchase program.
Net Cash from Operations Remained strong at $401 million, driven by both improved EBITDA and ongoing working capital discipline amid fluctuating market prices and ongoing inflation. Year-to-date net cash flow from operations was $1.1 billion, significantly higher compared to last year.
Net Debt-to-Adjusted EBITDA Ratio Improved to 1.76x, below the long-term target range, underscoring the health of the balance sheet.
Canada Sector Revenue Up 4% and year-to-date growth of 5%, driven by strong commercial execution, higher sales volume, and a more profitable mix supported by growth in value-added milk versus core white milk and continued gains in cheese and cultured products.
Canada Sector Adjusted EBITDA Up 8%, reaching $189 million, driven by higher volume, favorable mix, and efficiency gains from automation and production investment.
U.S. Sector Revenue Came in at $2.1 billion, down 7% from last year, mainly reflecting lower U.S. dairy commodity prices, especially butter and cheese block prices. Pricing actions to offset inflation and higher dairy ingredient market prices helped mitigate part of the decline.
U.S. Sector Adjusted EBITDA Was $185 million, up 16%, driven by volume growth, favorable mix, and operational improvement. Efficiency initiatives and benefits from recent capital investments contributed positively.
International Sector Revenue Was $994 million, down 3% from last year. Higher sales volume was supported by improved milk availability in Argentina, while lower export volume in Australia was partially offset by stronger domestic sales.
International Sector Adjusted EBITDA Was $82 million, up 61%, driven by higher volumes, product mix optimization, and a much more favorable relationship between international prices and milk costs.
Europe Sector Revenue Was $336 million, up 8% from last year, driven by higher sales volume supported by increased advertising and promotional activity behind the branded cheese portfolio.
Europe Sector Adjusted EBITDA Came in at $36 million, up 16%, with margin improving to 11%, driven by a more favorable balance between selling prices and input costs, supported by higher volumes.
New product launches: The Armstrong protein line and new Dairyland and Neilson protein beverages are gaining meaningful traction. A major national foodservice partner exceeded expectations with its protein beverage platform.
High-protein innovations: Investments in high-protein, functional, and value-added dairy categories are being emphasized, leveraging scale and brand strength across retail and foodservice.
Market expansion in Canada: Sales volumes increased year-over-year with broad-based category growth. Expanded presence with major retail banners and smaller independent grocers.
Global export markets: Favorable relationship between selling prices and milk costs supported growth. Mozzarella category delivered solid growth in export markets.
Europe market: Cathedral City brand achieved strong volume growth and household penetration gains, supported by marketing and consumer engagement.
Operational efficiencies: Automation initiatives in Canada delivered meaningful cost reductions. Consolidation of Green Bay plant into Franklin facility increased output by 30%.
Cost management: Disciplined cost management and SG&A optimization helped mitigate inflationary pressures and higher wages.
Network optimization: Modernization and optimization of facilities, including upgraded whey protein systems and new lactose dryer in Waupun, Wisconsin, improved efficiency and product quality.
Strategic focus on high-protein dairy: Aligned with dietary guidelines emphasizing high-quality protein, calcium, and key vitamins. Investments in high-protein and value-added dairy categories.
Brand building and innovation: Strengthened brand engagement with awards and recognition for brands like Dairyland, Neilson, and Armstrong. Alexis de Portneuf earned medals at the World Cheese Awards.
Market Volatility: The U.S. commodities landscape experienced high volatility this quarter, particularly in dairy commodity prices such as butter and cheese block prices. This volatility is expected to persist, impacting overall results and creating challenges in market recalibration.
Macroeconomic Volatility in Argentina: Inflation and currency trends in Argentina showed some moderation but remain dynamic, posing ongoing challenges in managing raw material costs and navigating the macroeconomic environment.
Inflationary Pressures: Inflationary pressures continue to affect domestic markets, requiring ongoing pricing actions to mitigate higher input costs and maintain customer confidence.
Labor and Compensation Costs: Higher labor and compensation costs were noted across sectors, adding to operational expenses and requiring offsetting measures such as SG&A optimization.
Supply Chain and Network Optimization: The closure of the Green Bay, Wisconsin facility and the transfer of production to the Franklin site, while improving efficiency, involved transitional costs and operational adjustments.
Export Market Challenges: Lower export volumes in Australia were partially offset by domestic sales, but export market dynamics remain a challenge.
Economic Uncertainty in Europe: Softer retail volumes in non-cheese categories and lower market prices for bulk cheese sales were noted, reflecting economic uncertainties in the region.
Revenue Expectations: The company anticipates continued strong consumer demand for high-protein dairy options, supported by favorable nutrition guidelines and evolving consumer preferences. However, U.S. commodity markets are expected to remain volatile through the remainder of the fiscal year and into the next year.
Margin Projections: Operational efficiencies, cost management, and network optimization are expected to drive sustained margin expansion across all sectors. The company is leveraging automation and production investments to reduce costs and strengthen its position as a low-cost producer.
Capital Expenditures: The company has invested approximately $180 million in upgraded whey protein systems and a new lactose dryer at its Waupun, Wisconsin facility, boosting WPC80 output by 35% and enhancing product quality. These investments are expected to position the company as a leader in high-value protein and lactose solutions.
Market Trends: The company expects a gradual recalibration of U.S. commodity markets as consumer-facing promotions expand and industry demand strengthens. Globally, the demand for high-quality dairy protein is expected to grow, supported by favorable dietary guidelines and consumer interest in nutritious, value-added dairy products.
Business Segment Performance: In the U.S., the company is scaling up its consolidated Midwest warehouse and optimizing its Franklin facility, which has boosted output by 30%. In Canada, the company is experiencing record profitability driven by automation initiatives and strong consumer demand. In Europe, branded cheese portfolios are gaining momentum, supported by marketing investments. In Australia, higher export pricing and seasonally stronger milk intake are driving growth.
Dividend Payments: Through the first 9 months of the year, Saputo returned $646 million to shareholders via dividends and share repurchases.
Share Repurchase Program: Saputo repurchased 12.6 million shares under its NCIB (Normal Course Issuer Bid) program, contributing to the $646 million returned to shareholders.
The earnings call summary and Q&A indicate a positive outlook. Strong financial metrics, such as a significant increase in in-force business margins and a well-progressed portfolio repositioning, suggest long-term growth. The positive sentiment is reinforced by a robust new business pipeline, strategic capital deployment, and a clear shareholder return plan. While there are some uncertainties in the Q&A, the overall strategic plan and optimistic guidance outweigh these concerns, suggesting a positive stock price movement.
The earnings call summary indicates strong financial performance with a 7.4% premium growth, increased book value, and better-than-expected variable investment income. The Q&A highlights strategic moves like exiting the U.S. health care business and focusing on high-return areas, with positive guidance for 2026. Although there are concerns about management's lack of specificity, the overall sentiment is positive due to optimistic EPS growth targets, shareholder returns, and strategic capital deployment. The absence of a market cap suggests a likely moderate stock price reaction, leading to a 'Positive' sentiment rating.
The earnings call summary highlights strong financial metrics, capital flexibility, and shareholder return plans, which are positive indicators. The Q&A section reveals normal volatility in claims and deployable excess capital. While guidance remains unchanged, the company anticipates future profitability and market expansion, suggesting optimism. The lack of new partnerships or secondary offerings, and the absence of guidance refusal, further supports a positive outlook. Therefore, considering all factors, the stock price is likely to experience a positive movement of 2% to 8% over the next two weeks.
The earnings call summary provides a mixed picture: while there are positive elements such as expected margin improvements, potential share repurchases, and a strong pipeline, there are also concerns about higher claims costs and uncertainty in the healthcare line. The Q&A section reveals cautious optimism but also highlights some uncertainties, particularly regarding future guidance and earnings volatility. This balance of positive and negative factors suggests a neutral sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.